2C-C-NBOMe

2C-C-NBOMe

Systematic (IUPAC) name
2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
Clinical data
Pregnancy cat.	?
Legal status	Class C (NZ)
Identifiers
CAS number	1227608-02-7 N
ATC code	?
PubChem	CID 46856354
ChemSpider	24583389 Y
Chemical data
Formula	C18H22ClNO3
Mol. mass	335.824 g/mol
SMILES	eMolecules & PubChem
InChI InChI=1S/C18H22ClNO3/c1-21-16-7-5-4-6-14(16)12-20-9-8-13-10-18(23-3)15(19)11-17(13)22-2/h4-7,10-11,20H,8-9,12H2,1-3H3 Y Key:FJFPOGCVVLUYAQ-UHFFFAOYSA-N Y
N (what is this?)  (verify)

2C-C-NBOMe (NBOMe-2C-C, 25C-NBOMe, Cimbi-82, Pandora, Dime) is a derivative of the phenethylamine hallucinogen 2C-C, which acts as a potent partial agonist for the 5HT_2A receptor, and has been studied in its ¹¹C radiolabelled form as a potential ligand for mapping the distribution of 5-HT_2A receptors in the brain, using positron emission tomography (PET).^[1] Anecdotal reports from human users suggest 2C-C-NBOMe to be an active hallucinogen at a dose of as little as 200-500mcg insufflated, making it only slightly less potent than LSD.^{[citation needed]} It was discovered to be on sale as a designer drug in New Zealand in early 2012, but was withdrawn from sale after a statement by Associate Health Minister Peter Dunne that 25C-NBOMe would be considered to be substantially similar in chemical structure to the illegal hallucinogen DOB, and therefore a Class C controlled drug analogue.^[2][3][4]

See also

• 2CBCB-NBOMe (NBOMe-TCB-2)
• 2CBFly-NBOMe (NBOMe-2CB-Fly)
• 25B-NBOMe (NBOMe-2CB)
• 25I-NBOMe (NBOMe-2CI)
• 2C-TFM-NBOMe (NBOMe-2C-TFM)
• 25I-NBMD (NBMD-2CI)
• 25I-NBOH (NBOH-2CI)
• 25I-NBF (NBF-2CI)
• 5-MeO-NBpBrT

References

This psychedelics, dissociatives and deliriants-related article is a stub. You can help Wikipedia by expanding it. v t e